Isolation and Characterization of Circulating Tumor Cells in Patients with Metastatic Colorectal Cancer
- 1 July 2006
- journal article
- Published by Elsevier BV in Clinical Colorectal Cancer
- Vol. 6 (2), 125-132
- https://doi.org/10.3816/ccc.2006.n.029
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Cancer Statistics, 2006CA: A Cancer Journal for Clinicians, 2006
- Modulation of Fluorouracil by Leucovorin in Patients With Advanced Colorectal Cancer: An Updated Meta-AnalysisJournal of Clinical Oncology, 2004
- Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast CancerNew England Journal of Medicine, 2004
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal CancerNew England Journal of Medicine, 2004
- A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal CancerJournal of Clinical Oncology, 2004
- Changes in circulating carcinoma cells in patients with metastatic prostate cancer correlate with disease statusUrology, 2001
- Comparative Analysis of Tumor Cell Dissemination in Mesenteric, Central, and Peripheral Venous Blood in Patients With Colorectal CancerArchives of Surgery, 2001
- Detection and characterization of carcinoma cells in the bloodProceedings of the National Academy of Sciences, 1998
- Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon CarcinomaNew England Journal of Medicine, 1990